103 related articles for article (PubMed ID: 16273724)
1. Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood.
Win N; Madan B; Gale R; Matthey F
Hematology; 2005 Oct; 10(5):375-8. PubMed ID: 16273724
[TBL] [Abstract][Full Text] [Related]
2. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
Win N; Sinha S; Lee E; Mills W
Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
[TBL] [Abstract][Full Text] [Related]
3. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.
Cullis JO; Win N; Dudley JM; Kaye T
Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease.
Win N; Yeghen T; Needs M; Chen FE; Okpala I
Hematology; 2004; 9(5-6):433-6. PubMed ID: 15763986
[TBL] [Abstract][Full Text] [Related]
5. Prevention of potential delayed hemolytic transfusion reaction in two sickle cell patients using intravenous immunoglobulins and steroids before and after red blood cell exchange with antigen positive units and review literature.
Shold J; Dasgupta A; Ye Z
Transfus Apher Sci; 2024 Jun; 63(3):103920. PubMed ID: 38570214
[TBL] [Abstract][Full Text] [Related]
6. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
Win N; New H; Lee E; de la Fuente J
Transfusion; 2008 Jun; 48(6):1231-8. PubMed ID: 18373500
[TBL] [Abstract][Full Text] [Related]
7. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
Morgan S; Sorensen P; Vercellotti G; Zantek ND
Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion-Transmitted Injuries Surveillance System (Ontario).
Batarfi K; Liu Y; Nixon J; Webert KE; John MS; Karunakaran M; Alhomsi N; Park JJ; Heddle NM
Vox Sang; 2023 Sep; 118(9):753-762. PubMed ID: 37592865
[TBL] [Abstract][Full Text] [Related]
9. Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
Win N; Needs M; Thornton N; Webster R; Chang C
Transfusion; 2018 Jul; 58(7):1626-1630. PubMed ID: 29732576
[TBL] [Abstract][Full Text] [Related]
10. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
Win N; Lee E; Needs M; Chia LW; Stasi R
Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
Uhlmann EJ; Shenoy S; Goodnough LT
Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
[TBL] [Abstract][Full Text] [Related]
13. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F
Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
[TBL] [Abstract][Full Text] [Related]
14. The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin-associated hemolysis.
Tong TN; Blacquiere M; Sakac D; Burke-Murphy E; Yi Q; Callum J; Cserti-Gazdewich C; Parmar N; Shehata N; Pavenski K; Lau W; Lin Y; Lieberman L; Branch DR; Pendergrast J
Transfusion; 2020 Dec; 60(12):3010-3018. PubMed ID: 33091964
[TBL] [Abstract][Full Text] [Related]
15. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
Gardner K; Hoppe C; Mijovic A; Thein SL
Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
[TBL] [Abstract][Full Text] [Related]
16. An animal model for delayed hemolytic transfusion reactions.
Ness PM; Shirey RS; Weinstein MH; King KE
Transfus Med Rev; 2001 Oct; 15(4):305-17. PubMed ID: 11668437
[TBL] [Abstract][Full Text] [Related]
17. Refractory hyperhaemolysis in a patient with beta-thalassaemia major.
Grainger JD; Makar Y; McManus A; Wynn R
Transfus Med; 2001 Feb; 11(1):55-7. PubMed ID: 11328573
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis upon intravenous immunoglobulin transfusion.
Padmore RF
Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
